Review
doi: 10.1146/annurev.med.60.101107.134802.Cancer screening: the clash of science and intuition
Affiliations
- PMID:18803476
- DOI: 10.1146/annurev.med.60.101107.134802
Item in Clipboard
Review
Cancer screening: the clash of science and intuition
Barnett S Kramer et al. Annu Rev Med.2009.
Display options
Format
Display options
Format
Abstract
The concept of early detection of cancer holds great promise and intuitive appeal. However, powerful biases can mislead clinicians when evaluating the efficacy of screening tests by clinical observation alone. Selection bias, lead-time bias, length-biased sampling, and overdiagnosis are counterintuitive concepts with critical implications for early-detection efforts. This article explains these biases and other common confounders in cancer screening. The most direct and reliable way to avoid being led astray by intuitions is through the use of randomized controlled trials.
Similar articles
- The science of early detection.Kramer BS.Kramer BS.Urol Oncol. 2004 Jul-Aug;22(4):344-7. doi: 10.1016/j.urolonc.2003.04.001.Urol Oncol. 2004.PMID:15283894Review.
- Screening for cancer: evaluating the evidence.Gates TJ.Gates TJ.Am Fam Physician. 2001 Feb 1;63(3):513-22.Am Fam Physician. 2001.PMID:11272300Review.
- [Problems in using survival data of cancer patients as a method of gauging the effectiveness of cancer control efforts].Oshima A.Oshima A.Gan No Rinsho. 1988 Oct;34(12):1637-41.Gan No Rinsho. 1988.PMID:3193607Japanese.
- Bias in breast cancer research in the screening era.Cox B, Sneyd MJ.Cox B, et al.Breast. 2013 Dec;22(6):1041-5. doi: 10.1016/j.breast.2013.07.046. Epub 2013 Aug 26.Breast. 2013.PMID:23988397Review.
- Cancer screenings, diagnostic technology evolution, and cancer control.Stracci F.Stracci F.Methods Mol Biol. 2009;471:107-36. doi: 10.1007/978-1-59745-416-2_6.Methods Mol Biol. 2009.PMID:19109777
Cited by
- Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development (carcino-evo-devo).Kozlov AP.Kozlov AP.Infect Agent Cancer. 2022 Jan 10;17(1):2. doi: 10.1186/s13027-021-00412-0.Infect Agent Cancer. 2022.PMID:35012580Free PMC article.Review.
- Knowledge of and Attitudes Toward Evidence-Based Guidelines for and Against Clinical Preventive Services: Results from a National Survey.Lantz PM, Evans WD, Mead H, Alvarez C, Stewart L.Lantz PM, et al.Milbank Q. 2016 Mar;94(1):51-76. doi: 10.1111/1468-0009.12181.Milbank Q. 2016.PMID:26994709Free PMC article.
- Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B.Aghoram R, Cai P, Dickinson JA.Aghoram R, et al.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD002799. doi: 10.1002/14651858.CD002799.pub2.Cochrane Database Syst Rev. 2012.PMID:22972059Free PMC article.Review.
- Polyp size measurement at CT colonography: what do we know and what do we need to know?Summers RM.Summers RM.Radiology. 2010 Jun;255(3):707-20. doi: 10.1148/radiol.10090877.Radiology. 2010.PMID:20501711Free PMC article.Review.
- Screening: when things go wrong.Dickinson JA, Pimlott N, Grad R, Singh H, Szafran O, Wilson BJ, Groulx S, Thériault G, Bell NR.Dickinson JA, et al.Can Fam Physician. 2018 Jul;64(7):502-508.Can Fam Physician. 2018.PMID:30002025Free PMC article.No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources